Iveric Bio Inc
(ISEE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 254,895 | 36,720 | 39,568 | 39,814 | 94,804 |
| Marketable Securities | 26,147 | 412,320 | 393,718 | 423,746 | 313,978 |
| Receivables | N/A | N/A | N/A | N/A | 50,000 |
| Income taxes - deferred | 1,500 | 106 | 70 | N/A | 1,069 |
| Other current assets | 0 | 247 | 50,249 | 960 | 0 |
| TOTAL | $288,083 | $460,278 | $492,505 | $473,332 | $462,644 |
| Non-Current Assets | |||||
| PPE Net | 2,590 | 1,809 | 1,563 | 1,555 | 1,289 |
| Investments And Advances | 145,411 | 467 | 282 | 0 | 282 |
| Other Non-Current Assets | 14,667 | 8,495 | 4,491 | 4,899 | 26,271 |
| TOTAL | $162,668 | $10,771 | $6,336 | $6,454 | $27,842 |
| Total Assets | $450,751 | $471,049 | $498,841 | $479,786 | $490,486 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,850 | 6,150 | 5,757 | 8,707 | 6,706 |
| Accrued Expenses | 20,080 | 9,775 | 8,103 | 7,918 | 6,342 |
| TOTAL | $34,644 | $22,680 | $20,497 | $19,831 | $24,039 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,714 | 6,755 | 6,637 | 3,206 | 3,206 |
| Other Non-Current Liabilities | 125,000 | 125,000 | 125,000 | 125,000 | 83,333 |
| TOTAL | $332,996 | $334,593 | $336,309 | $331,418 | $290,552 |
| Total Liabilities | $367,640 | $357,273 | $356,806 | $351,249 | $314,591 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,960 | 34,742 | 34,298 | 34,174 | 33,651 |
| Common Shares | 35 | 35 | 34 | 34 | 34 |
| Retained earnings | -369,890 | -330,317 | -293,186 | -299,822 | -245,367 |
| Other shareholders' equity | 79 | 24 | -17 | -65 | 35 |
| TOTAL | $83,111 | $113,776 | $142,035 | $128,537 | $175,895 |
| Total Liabilities And Equity | $450,751 | $471,049 | $498,841 | $479,786 | $490,486 |